Rare diseases
Investigational molecules
Locations
-, 151 85 Sodertalje, Sweden
Oncology is the central area of research interest, with extensive activity across breast cancer, non-small cell lung cancer, ovarian cancer, prostate cancer, bladder cancer, gastric cancer, gastroesophageal junction adenocarcinoma, hepatocellular carcinoma, biliary tract cancer, pancreatic cancer, head and neck squamous cell carcinoma, and pleural mesothelioma. The sponsor also studies hematologic malignancies including chronic lymphocytic leukemia, mantle cell lymphoma, large B-cell lymphoma, multiple myeloma, acute leukemia, and myelodysplastic syndromes.
Research also includes advanced solid tumors with specific molecular features such as BRCA alterations, HER2 expression, PD-L1 expression, MET drive, CLDN18.2 expression, and other actionable genomic changes.
AstraZeneca AB runs clinical trials in conditions such as Non-small cell lung cancer, Asthma, Chronic obstructive pulmonary disease, Breast cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Bulgaria
AustriaBulgaria
FranceAustriaBulgariaBulgariaBulgaria
BelgiumBelgiumBelgiumAustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
